‌List of Figures

Fig. 1.1 Channel marketing

Fig. 1.2 Assemblage marketing

Fig. 1.3 Pseudonym system used in this book

Fig. 2.1 Stages of drug development

Fig. 3.1 A hypothetical trajectory of publications

Fig. 3.2 Contributors to the publication plan and manuscripts

Fig. 3.3 Multiple stakeholders in publication

Fig. 6.1 Segmenting patient populations to improve adherence

Fig. 7.1 The influence of advocates

Fig. 8.1 The goal of assemblage marketing